MetaCap

Health Catalyst Inc (HCAT)

NASDAQ: HCATTechnologyComputer Software: Programming Data ProcessingUSD

1.31+0.02 (+1.55%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

HCAT stock chart

Technical analysis

Key statistics

All statistics
Market cap
$99.76M
EPS (TTM)
-$2.80
52-week range
0.955 – 3.03
Day range
1.27 – 1.38
Volume / Avg
711.63K / 414.24K
Beta
—

52-week range

$0.955$3.03

HCAT stock today

Health Catalyst (HCAT) closed at $1.31 on Nov 20, up 1.55% (+$0.02), versus the S&P 500's 3.70% decline. At this level, HCAT sits near the bottom of its 52-week range of $0.955 to $3.03: 56.7% below the high, set on Nov 28, 2025 and 37.2% above the low. HCAT is down 45.2% year to date, underperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has lost 44.5%.

Health Catalyst has posted a net loss over the last twelve months (EPS of -$2.80), so its P/E ratio is not meaningful.

Summary generated from market data by MetaCap's automated system. Methodology

About Health Catalyst

Company profile

Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations in the United States. The company operates in two segments: Technology and Professional Services.

Industry
Computer Software: Programming Data Processing
CEO
Mr. Simeon M. Kohl
Headquarters
South Jordan, UT
Employees
1,200
IPO year
2019

Financial highlights

Full financials

In fiscal 2025, Health Catalyst generated $311.1 million in revenue, up 1.5% from fiscal 2024, its 8th consecutive year of revenue growth. Health Catalyst reported a net loss of $178.0 million, compared with a loss of $69.5 million a year earlier. Gross margin was 48.7% (up from 45.9%) and operating margin -51.7%.

Health Catalyst annual revenue, net income and EPS
Fiscal yearFY 2025FY 2024FY 2023FY 2022FY 2021
Revenue$311.14M$306.58M$295.94M$276.24M$241.93M
Growth+1.48%+3.60%+7.13%+14.18%+28.11%
Net income$-177.97M$-69.50M$-118.15M$-137.40M$-153.21M
EPS (diluted)$-2.55$-1.15$-2.09$-2.63$-3.23

Analyst forecast

Forecast

Consensus (5 analysts)

hold

Avg. price target

$1.77+35.11%

  • Strong buy 0
  • Buy 1
  • Hold 4
  • Sell 0
  • Strong sell 0

Target range

Low $1.50High $2.00

Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.

Earnings

Earnings history
Last reported (Sep/2026)
Nov 5, 2026
EPS actual vs est.
$0.53 vs $-0.07
Surprise
+857.14%

HCAT news

All HCAT news

Health Catalyst peers

Technology sector
HCAT peer companies
CompanyPrice% ChgMarket capCompare
DOYUDouYu International Holdings Limited ADS3.25+3.50%$98.08Mvs HCAT
DSCDSC Holdings Ltd. ADR1.91-5.91%$95.64Mvs HCAT
GMMGlobal Mofy AI Limited Class A1.39-27.60%$80.27Mvs HCAT
PODCPodcastOne Inc.1.79-2.19%$56.04Mvs HCAT
SANGSangoma Technologies Corporation4.63-1.91%$155.22Mvs HCAT
SOGPSound Group Inc. ADR8.13-13.51%$34.06Mvs HCAT
JGAurora Mobile Limited ADR5.91-1.17%$33.89Mvs HCAT
GOAIEva Live Inc.0.5242+1.96%$21.56Mvs HCAT

Indexes, lists and sector

Health Catalyst stock FAQ

What is Health Catalyst's stock price today?

HCAT last traded at $1.31 as of Nov 20, 4:00 PM EST, up 1.55% on the day. Prices are delayed at least 15 minutes.

Who is Health Catalyst's CEO?

Mr. Simeon M. Kohl is the chief executive officer of Health Catalyst Inc, which has about 1,200 employees.

What is the HCAT 52-week high?

The 52-week high for HCAT is $3.03 and the 52-week low is $0.955. The stock is currently 56.7% below its high.

Compare HCAT